This compound is a fluorinated nucleoside analog intermediate, featuring a uracil base attached to a modified ribose sugar with acetyl protecting groups. It is primarily used in the synthesis of nucleoside analogs for pharmaceutical research and manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 10212-13-2
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate
pharmaceutical intermediate
2-Deoxy-2,2-difluoro-alpha-D-erythro-pentofuranose 3,5-dibenzoate 1-methanesulfonate
pharmaceutical intermediate
2-Deoxy-alpha-D-erythropentofuranose 1-acetate 3,5-bis(4-chlorobenzoate)
pharmaceutical intermediate
9-(2-Deoxy-2-fluoroarabinofuranosyl)guanine
pharmaceutical intermediate
2'-fluoro-2'-deoxycytidine
pharmaceutical intermediate
(3S)-3-(tert-Butoxycarbonyl)amino-1-chloro-4-phenyl-2-butanone
pharmaceutical intermediate
1-(cyclopropylcarbonyl)piperazine hydrochloride
pharmaceutical intermediate
2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile
pharmaceutical intermediate
[(2R,3R,4R,5R)-3-acetyloxy-5-(2,4-dioxopyrimidin-1-yl)-4-fluorooxolan-2-yl]methyl acetate
SGWNQYIJJOVQCM-HJQYOEGKSA-N
CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=O)NC2=O)F)OC(=O)C
—